Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAPGet Free Report) have been assigned a consensus rating of “Moderate Buy” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, three have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $16.3750.

CCAP has been the subject of a number of research reports. Oppenheimer decreased their target price on Crescent Capital BDC from $20.00 to $19.00 and set an “outperform” rating for the company in a research note on Friday, November 14th. Keefe, Bruyette & Woods reduced their price objective on Crescent Capital BDC from $17.00 to $15.50 and set an “outperform” rating for the company in a research report on Friday, November 14th. Wells Fargo & Company dropped their target price on Crescent Capital BDC from $15.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Friday, November 14th. Wall Street Zen cut Crescent Capital BDC from a “hold” rating to a “sell” rating in a research note on Saturday, November 15th. Finally, LADENBURG THALM/SH SH upgraded shares of Crescent Capital BDC to a “strong-buy” rating in a research report on Friday, August 15th.

Read Our Latest Stock Analysis on Crescent Capital BDC

Crescent Capital BDC Stock Up 2.3%

Shares of NASDAQ:CCAP opened at $14.90 on Friday. The company’s fifty day moving average is $14.05 and its two-hundred day moving average is $14.64. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.20 and a current ratio of 1.20. Crescent Capital BDC has a 1-year low of $13.03 and a 1-year high of $20.19. The stock has a market capitalization of $551.15 million, a price-to-earnings ratio of 15.20 and a beta of 0.55.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last posted its quarterly earnings results on Wednesday, November 12th. The company reported $0.46 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.01). The business had revenue of $41.35 million during the quarter, compared to analyst estimates of $42.35 million. Crescent Capital BDC had a net margin of 20.84% and a return on equity of 9.76%. Equities analysts anticipate that Crescent Capital BDC will post 2.09 EPS for the current year.

Crescent Capital BDC Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Wednesday, December 31st will be given a $0.42 dividend. The ex-dividend date is Wednesday, December 31st. This represents a $1.68 annualized dividend and a yield of 11.3%. Crescent Capital BDC’s dividend payout ratio is 171.43%.

Hedge Funds Weigh In On Crescent Capital BDC

Hedge funds and other institutional investors have recently made changes to their positions in the business. Alpine Global Management LLC acquired a new stake in Crescent Capital BDC in the 3rd quarter valued at approximately $3,137,000. Two Sigma Investments LP grew its stake in shares of Crescent Capital BDC by 199.6% in the third quarter. Two Sigma Investments LP now owns 269,649 shares of the company’s stock worth $3,845,000 after purchasing an additional 179,660 shares in the last quarter. Bulldog Investors LLP increased its holdings in shares of Crescent Capital BDC by 50.7% during the third quarter. Bulldog Investors LLP now owns 437,518 shares of the company’s stock valued at $6,239,000 after purchasing an additional 147,135 shares during the period. North Ground Capital raised its stake in shares of Crescent Capital BDC by 34.4% during the third quarter. North Ground Capital now owns 418,000 shares of the company’s stock valued at $5,961,000 after purchasing an additional 107,000 shares in the last quarter. Finally, Jane Street Group LLC acquired a new stake in Crescent Capital BDC in the second quarter worth about $1,448,000. 49.46% of the stock is currently owned by institutional investors and hedge funds.

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Articles

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.